SCHEMBL7746568

SCHEMBL7746568

O=C(Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1C1=CC(=S)CC=C1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.41
FLT1 P17948 1/20 0.41
FLT4 P35916 1/20 0.41
HDAC1 Q13547 6/20 0.39
HDAC2 Q92769 2/20 0.39
EGFR P00533 2/20 0.35
GAA P10253 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 2/20 0.34
ADCY8 P40145 1/20 0.34
ADCY1 Q08828 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
KDM4E B2RXH2 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HDAC3 O15379 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986013 0.95 KDR (0.39) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7986526 0.93 KDR (0.42) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7969457 0.93 KDR (0.42) KDRFLT1FLT4GAASMN1; SMN2
SCHEMBL7980106 0.93 KDR (0.42) KDRFLT1FLT4HDAC2GAA
SCHEMBL7739003 0.91 HPN (0.44) KDRFLT1FLT4HDAC2SMN1; SMN2
SCHEMBL7744769 0.90 KDR (0.53) KDRFLT1FLT4HDAC1HDAC2
SCHEMBL7969509 0.90 MCL1 (0.38) KDRFLT1FLT4GAASMN1; SMN2
SCHEMBL7744069 0.85 KDR (0.40) KDRFLT1FLT4HDAC1GAA
SCHEMBL7982717 0.83 KDR (0.44) KDRFLT1FLT4GAAMEN1
SCHEMBL7746598 0.82 KDR (0.58) KDRFLT1FLT4HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed